Dr. Albitar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
175 Technology Dr.
Irvine, CA 92618Phone+1 657-202-5950Fax+1 949-301-9719
Education & Training
- Damascus University Faculty of MedicineClass of 1979
Certifications & Licensure
- CA State Medical License 2003 - 2027
- DC State Medical License 2023 - 2027
- FL State Medical License 2017 - 2027
- CT State Medical License 2023 - 2026
- MD State Medical License 2023 - 2026
- PA State Medical License 1986 - 2026
- RI State Medical License 1984 - 2026
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- Join now to see all
Publications & Presentations
PubMed
- Updates on the Biological Heterogeneity of Mantle Cell Lymphoma.Andrew Ip, Maciej Kabat, Lindsay Fogel, Hassan Alkhatatneh, Jason Voss
Cancers. 2025-02-19 - cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid Malignancies.Scott D Rowley, Maher Albitar, Melissa F Baker, Alaa Ali, Sukhdeep Kaur
Cancers. 2025-02-13 - mRNA Expression in DLBCL Patients who are CD20 Dim With an Eye Towards More Thoughtful Design of R/R Trials, Possibly Incorporating BCMA Bite Therapy.Bruce Hough, Maher Albitar
Clinical Lymphoma, Myeloma & Leukemia. 2025-02-02
Press Mentions
- Genomic Testing Cooperative and Its Co-Op Members First to Use Artificial Intelligence to Distinguish Between 45 Hematologic and Solid Neoplasms Using Targeted TranscriptomeOctober 13th, 2022
- CorePath Laboratories Internalizes Genomic Testing Cooperative's State-of-the-Art Next-Generation Sequencing (NGS) Testing for Solid Tumors and Hematologic NeoplasmsMay 16th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: